EUVIMEDEUVIMED entdecken
Crossref

A machine learning algorithm for stratification of risk of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease

Naoki Shibata, Yasuhiro Morita, Takanori Ito, Yasunori Kanzaki, Naoki Watanabe, Naoki Yoshioka, Yoshihito Arao, Satoshi Yasuda, Yuichi Koshiyama, Hidenori Toyoda, Itsuro Morishima

European Journal of Internal Medicine · 2024

DOI: 10.1016/j.ejim.2024.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Internal Medicine, 2024. Verfasst von Naoki Shibata und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan. Hauptthemen laut MEDLINE: Machine Learning, Cardiovascular Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Steatotic liver disease (SLD) is associated with adverse cardiac events. Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a condition characterized by the abnormal accumulation of hepatic lipids that is closely linked to five metabolic disorders: overweight or obesity, impaired glucose regulation, hypertension, hypertriglyceridemia, and low high-density lipoprotein-cholesterol. This retrospective study aimed to stratify the risk of cardiac events in patients with MASLD. METHODS: Patients diagnosed with MASLD through ultrasonography were evaluated. We implemented a machine learning-based approach using a survival classification and regression tree (CART) model to stratify patients based on age, and the number of risk scores was investigated as a predictor of adverse outcomes in the derivation cohort. The primary outcomes were major adverse cardiac events (MACE) including cardiac death, nonfatal myocardial infarction, and revascularization due to coronary artery disease. RESULTS: Among 2,962 patients (median age, 62 years; men, 53.5 %), the distribution of risk factors was as follows: one (10.8 %), two (28.5 %), three (33.0 %), four (19.9 %), and five (7.8 %). Over a median follow-up period of 6.8 years, 170 (5.7 %) patients experienced MACE. In the derivation cohort of 2,073 patients, the CART model identified age ≥60 years old and risk factors ≥4 as significant predictors of MACE. These findings were corroborated in a validation cohort of 889 patients. Patients meeting both criteria exhibited the highest risk of MACE (log-rank test, p < 0.001). CONCLUSIONS: Patients aged ≥60 years old with risk factors ≥4 indicates at high risk of MACE in patients with MASLD. This risk stratification system provides a practical tool for identifying high-risk individuals in the MASLD population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningCardiovascular DiseasesHumansMaleFemaleMiddle AgedRetrospective StudiesAgedRisk AssessmentRisk FactorsAlgorithmsFatty Liver

Stichwörter der Autor:innen

Cardiometabolic criteriaMajor adverse cardiac eventMetabolic dysfunction-associated steatotic liver diseaseSurvival classification and regression tree

Autor:innen und Institutionen

  • Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan. Electronic address: morishima-i@muc.biglobe.ne.jp.

Zitieren

APA

Shibata, N., Morita, Y., Ito, T., Kanzaki, Y., Watanabe, N., Yoshioka, N., Arao, Y., Yasuda, S., Koshiyama, Y., Toyoda, H., & Morishima, I. (2024). A machine learning algorithm for stratification of risk of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2024.07.005

Vancouver

Shibata N, Morita Y, Ito T, Kanzaki Y, Watanabe N, Yoshioka N, et al. A machine learning algorithm for stratification of risk of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease. European Journal of Internal Medicine. 2024. doi:10.1016/j.ejim.2024.07.005

BibTeX
@article{Shibata2024,
  author = {Shibata, Naoki and Morita, Yasuhiro and Ito, Takanori and Kanzaki, Yasunori and Watanabe, Naoki and Yoshioka, Naoki and Arao, Yoshihito and Yasuda, Satoshi and Koshiyama, Yuichi and Toyoda, Hidenori and Morishima, Itsuro},
  title = {A machine learning algorithm for stratification of risk of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease},
  journal = {European Journal of Internal Medicine},
  year = {2024},
  doi = {10.1016/j.ejim.2024.07.005}
}
Kostenlos starten →